0000950170-24-138185.txt : 20241218 0000950170-24-138185.hdr.sgml : 20241218 20241218214744 ACCESSION NUMBER: 0000950170-24-138185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241216 FILED AS OF DATE: 20241218 DATE AS OF CHANGE: 20241218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THUT ANDREW CENTRAL INDEX KEY: 0001800579 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56075 FILM NUMBER: 241560827 MAIL ADDRESS: STREET 1: 5060 N. 40TH STREET, SUITE 120 CITY: PHOENIX STATE: AZ ZIP: 85018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 4Front Ventures Corp. CENTRAL INDEX KEY: 0001783875 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834168417 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7010 E. CHAUNCEY LANE STE. 235 CITY: PHOENIX STATE: AZ ZIP: 85054 BUSINESS PHONE: (602) 633-3067 MAIL ADDRESS: STREET 1: 7010 E. CHAUNCEY LANE STE. 235 CITY: PHOENIX STATE: AZ ZIP: 85054 4 1 ownership.xml 4 X0508 4 2024-12-16 0001783875 4Front Ventures Corp. FFNTF 0001800579 THUT ANDREW C/O 4FRONT VENTURES CORP. 7010 E. CHAUNCEY LANE, SUITE 235 PHOENIX AZ 85054 false true false false Chief Executive Officer false Stock Option (right to buy) 0.01 2024-12-16 4 A false 8045600 A 2029-12-16 Class A Subordinate Voting Shares 8045600 14011040 D Stock Option (right to buy) 0.14 2024-12-16 4 D false 8045600 D 2028-06-23 Class A Subordinate Voting Shares 8045600 0 D Stock Option (right to buy) 0.01 2024-12-16 4 A false 4000000 A 2029-12-16 Class A Subordinate Voting Shares 4000000 14011040 D Stock Option (right to buy) 0.17 2024-12-16 4 D false 4000000 D 2028-04-21 Class A Subordinate Voting Shares 4000000 0 D Stock Option (right to buy) 0.01 2024-12-16 4 A false 1965440 0 A 2029-12-16 Class A Subordinate Voting Shares 1965440 14011040 D Converted from CAD$0.02 based on CAD-USD Bank of Canada exchange rate of 1.4239 on December 16, 2024. Two-thirds of the options vested upon grant, and one-third of the options vest on December 31, 2024. The Reporting Person agreed to cancellation of an option granted on June 23, 2023, in exchange for a new option having a lower exercise price. Converted from Canadian exercise price of C$0.19 using an exchange rate of C$1.3199 = US$1.00 as of June 23, 2023. The options vested one-third on December 23, 2023, one-third on June 23, 2024, and one-third on December 23, 2024. Fully vested upon grant. The Reporting Person agreed to cancellation of an option granted on April 18, 2023, in exchange for a new option having a lower exercise price. Converted from Canadian exercise price of C$0.23 using an exchange rate of C$1.3387 = US$1.00 as of April 18, 2023. No options vest until April 18, 2024, then 1/24th of the options vest each month. /s/ Andrew Thut 2024-12-18